Related Experiment Video
Updated: May 3, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
A synthetic lethal interaction between APC/C and topoisomerase poisons uncovered by proteomic screens
Manuel Eguren1, Mónica Álvarez-Fernández1, Fernando García2
1Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Abstract:
The Anaphase-promoting complex/cyclosome (APC/C) cofactor Cdh1 modulates cell proliferation by targeting multiple cell-cycle regulators for ubiquitin-dependent degradation. Lack of Cdh1 results in structural and numerical chromosome aberrations, a hallmark of genomic instability. By using a proteomic approach in Cdh1-null cells and mouse tissues, we have identified kinesin Eg5 and topoisomerase 2α as Cdh1 targets involved in the maintenance of genomic stability. These proteins are ubiquitinated and degraded through specific KEN and D boxes in a Cdh1-dependent manner. Whereas Cdh1-null cells display partial resistance to Eg5 inhibitors such as monastrol, lack of Cdh1 results in a dramatic sensitivity to Top2α poisons as a consequence of increased levels of trapped Top2α-DNA complexes. Chemical inhibition of the APC/C in cancer cells results in increased sensitivity to Top2α poisons. This work identifies in vivo targets of the mammalian APC/C-Cdh1 complex and reveals synthetic lethal interactions of relevance in anticancer treatments.
Insights
The Anaphase-promoting complex/cyclosome (APC/C) cofactor Cdh1 targets proteins to maintain genomic stability. Loss of Cdh1 increases sensitivity to Topoisomerase 2α poisons, suggesting new cancer treatment strategies.
Area of Science:
- Cell Biology
- Genetics
- Molecular Biology
Background:
- The Anaphase-promoting complex/cyclosome (APC/C) cofactor Cdh1 regulates cell proliferation by degrading cell-cycle proteins.
- Cdh1 deficiency leads to chromosome instability, a characteristic of cancer.
Purpose of the Study:
- To identify novel Cdh1 targets involved in maintaining genomic stability.
- To explore the therapeutic implications of APC/C-Cdh1 function in cancer.
Main Methods:
- Proteomic analysis in Cdh1-null cells and mouse tissues.
- Ubiquitination and degradation assays.
- Sensitivity assays for Eg5 and Topoisomerase 2α inhibitors.
Main Results:
- Kinesin Eg5 and topoisomerase 2α (Top2α) were identified as novel Cdh1 targets.
- Cdh1-null cells showed resistance to Eg5 inhibitors but increased sensitivity to Top2α poisons.
- Inhibition of APC/C in cancer cells enhanced sensitivity to Top2α poisons.
Conclusions:
- Cdh1 directly regulates Eg5 and Top2α stability, crucial for genomic integrity.
- Targeting APC/C-Cdh1 interactions with Top2α poisons presents a potential synthetic lethal strategy for cancer therapy.
More Related Videos
Related Concept Videos
Anaphase Promoting Complex
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
The Intrinsic Apoptotic Pathway
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Inhibitors of Bacterial DNA Synthesis

